NTRA Natera Inc

USD 90.12 0.60 0.670241
Icon

Natera Inc (NTRA) Stock Analysis and Price Targets

COMMON STOCK | Diagnostics & Research | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 90.12

+0.60 (+0.67)%

USD 7.13B

0.84M

USD 74.69(-17.12%)

USD 62.50 (-30.65%)

Icon

NTRA

Natera Inc (USD)
COMMON STOCK | NSD
USD 90.12
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 7.13B

USD 62.50 (-30.65%)

USD 90.12

Natera Inc (NTRA) Stock Forecast

Show ratings and price targets of :
USD 74.69
(-17.12%)

Based on the Natera Inc stock forecast from 11 analysts, the average analyst target price for Natera Inc is USD 74.69 over the next 12 months. Natera Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Natera Inc is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, Natera Inc’s stock price was USD 90.12. Natera Inc’s stock price has changed by +0.94% over the past week, +28.72% over the past month and +59.14% over the last year.

No recent analyst target price found for Natera Inc
No recent average analyst rating found for Natera Inc

Company Overview Natera Inc

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test...Read More

https://www.natera.com

13011 McCallen Pass Building A, San Carlos, CA, United States, 78753

2,958

December

USD

USA

Adjusted Closing Price for Natera Inc (NTRA)

Loading...

Unadjusted Closing Price for Natera Inc (NTRA)

Loading...

Share Trading Volume for Natera Inc Shares

Loading...

Compare Performance of Natera Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for NTRA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Natera Inc (Sector: Diagnostics & Research )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
IDXX
IDEXX Laboratories Inc +0.04 (+0.01%) USD40.08B 49.24 34.23

ETFs Containing NTRA

Symbol Name NTRA's Weight Expense Ratio Price(Change) Market Cap
GNOM
Global X Genomics & Biote.. 6.92 % 0.50 % -0.12 (-1.05%) USD0.10B

Frequently Asked Questions About Natera Inc (NTRA) Stock

Based on ratings from 11 analysts Natera Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 15 buy, sell and 1 hold ratings.

Unfortunately we do not have enough data on NTRA's stock to indicate if its a good dividend stock.

Based on targets from 11 analysts, the average taret price for NTRA is USD 74.69 over the next 12 months. The maximum analyst target price is USD 110 while the minimum anlayst target price is USD 48.

Unfortunately we do not have enough data on NTRA's stock to indicate if its overvalued.

The last closing price of NTRA's stock was USD 90.12.

The most recent market capitalization for NTRA is USD 7.13B.

Based on targets from 11 analysts, the average taret price for NTRA is projected at USD 74.69 over the next 12 months. This means that NTRA's stock price may go down by -17.12% over the next 12 months.

Following are ETFs with the highest allocation to Natera Inc's stock :

GNOM

As per our most recent records Natera Inc has 2,958 Employees.

Natera Inc's registered address is 13011 McCallen Pass Building A, San Carlos, CA, United States, 78753. You can get more information about it from Natera Inc's website at https://www.natera.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...